A feature article in the August issue of Scientific American throws into question the concept of race-based drugs — how race is, or is not, meaningfully taken into account as a way to label genetic variation among individuals in clinical trials.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.